Your browser doesn't support javascript.
loading
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
Ko, Meehyun; Chang, So Young; Byun, Soo Young; Ianevski, Aleksandr; Choi, Inhee; Pham Hung d'Alexandry d'Orengiani, Anne-Laure; Ravlo, Erlend; Wang, Wei; Bjørås, Magnar; Kainov, Denis E; Shum, David; Min, Ji-Young; Windisch, Marc P.
Afiliación
  • Ko M; Respiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
  • Chang SY; Respiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
  • Byun SY; Screening Discovery Platform, Translation Research Division, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
  • Ianevski A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Choi I; Medicinal Chemistry, Medicinal Chemistry & Business Development Group, Translational Research Department, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
  • Pham Hung d'Alexandry d'Orengiani AL; Respiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
  • Ravlo E; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Wang W; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Bjørås M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Kainov DE; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Shum D; Institute of Technology, University of Tartu, 50090 Tartu, Estonia.
  • Min JY; Institute for Molecular Medicine Finland, University of Helsinki, 00100 Helsinki, Finland.
  • Windisch MP; Screening Discovery Platform, Translation Research Division, Institut Pasteur Korea, Seongnam 13488, Gyeonggi, Korea.
Viruses ; 13(4)2021 04 09.
Article en En | MEDLINE | ID: mdl-33918958
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Antivirales / Coronavirus del Síndrome Respiratorio de Oriente Medio / SARS-CoV-2 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Viruses Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Antivirales / Coronavirus del Síndrome Respiratorio de Oriente Medio / SARS-CoV-2 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Viruses Año: 2021 Tipo del documento: Article